Ifp Advisors, Inc Genmab A/S Transaction History

Ifp Advisors, Inc

$3.28 Billion
Q2 2025

A detailed history of Ifp Advisors, Inc transactions in Genmab A/S stock. As of the latest transaction made, Ifp Advisors, Inc holds 100 shares of GMAB stock, worth $2,876. This represents 0.0% of its overall portfolio holdings.

Number of Shares

100

Previous 120 16.67%

Holding current value

$2,876

Previous $2,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 24, 2025	SELL	$17.98 - $23.09 $359 - $461	-20 Reduced 16.67%	100 $2,000
Q1 2025 May 05, 2025	BUY	$18.69 - $24.14 $130 - $168	7 Added 6.19%	120 $2,000
Q4 2024 Feb 04, 2025	BUY	$20.02 - $24.15 $800 - $966	40 Added 54.79%	113 $2,000
Q3 2024 Feb 04, 2025	BUY	$23.84 - $28.48 $238 - $284	10 Added 15.87%	73 $1,000
Q1 2024 Jul 30, 2024	BUY	$26.43 - $32.77 $528 - $655	20 Added 46.51%	63 $1,000
Q3 2023 Oct 12, 2023	BUY	$35.27 - $42.24 $1,093 - $1,309	31 Added 258.33%	43 $1,000
Q2 2023 Aug 04, 2023	BUY	$37.4 - $42.94 $448 - $515	12 New	12 $0
Q4 2022 Feb 07, 2023	SELL	$33.8 - $47.06 $1,318 - $1,835	-39 Reduced 7.25%	499 $26,000
Q3 2022 Nov 08, 2022	BUY	$31.52 - $373.61 $1,229 - $14,570	39 Added 7.82%	538 $28,000
Q2 2022 Sep 06, 2022	BUY	$26.83 - $38.57 $13,388 - $19,246	499 New	499 $26,000
Q2 2022 Aug 12, 2022	SELL	$26.83 - $38.57 $13,388 - $19,246	-499 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$30.95 - $39.68 $15,444 - $19,800	499 New	499 $18,000
Q3 2021 Oct 06, 2021	SELL	$41.55 - $48.72 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$32.88 - $44.57 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$30.92 - $44.4 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$33.66 - $40.76 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	BUY	$33.07 - $38.68 $0 - $0	0 New	0 $0
Q2 2020 Aug 05, 2020	BUY	$20.05 - $33.89 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	BUY	$17.15 - $25.22 $0 - $0	0 New	0 $0

Others Institutions Holding GMAB

# of Institutions

255

Shares Held

65.7M

Call Options Held

32.5K

Put Options Held

55K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $18.9B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account